| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.53B | 52.98B | 43.66B | 42.66B | 39.70B | 57.41B |
| Gross Profit | 11.45B | 10.70B | 8.87B | 8.65B | 7.95B | 7.36B |
| EBITDA | 2.98B | 2.41B | 1.48B | 1.40B | 1.13B | 707.00M |
| Net Income | 4.22B | 3.72B | 1.16B | 1.02B | 781.00M | 278.00M |
Balance Sheet | ||||||
| Total Assets | 55.51B | 58.01B | 49.65B | 44.52B | 45.51B | 51.79B |
| Cash, Cash Equivalents and Short-Term Investments | 10.27B | 8.83B | 8.64B | 9.59B | 9.08B | 9.01B |
| Total Debt | 7.81B | 7.64B | 4.26B | 3.60B | 4.45B | 4.24B |
| Total Liabilities | 26.74B | 28.65B | 23.95B | 20.96B | 22.89B | 29.53B |
| Stockholders Equity | 28.76B | 29.36B | 25.68B | 23.55B | 22.62B | 22.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.04B | -1.26B | 1.22B | -753.00M | 332.00M |
| Operating Cash Flow | 0.00 | -798.00M | -1.01B | 1.59B | -510.00M | 648.00M |
| Investing Cash Flow | 0.00 | 245.00M | 353.00M | -37.00M | 951.00M | -7.00M |
| Financing Cash Flow | 0.00 | 1.12B | -498.00M | -1.67B | -628.00M | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥196.85B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.76B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.16B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
68 Neutral | ¥41.50B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% | |
65 Neutral | ¥30.89B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥14.61B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |